Hermetica Superfood Encyclopedia
The Short Answer
Copaiba (Copaifera officinalis) is an Amazonian tree resin containing β-caryophyllene, a cannabinoid receptor CB2 agonist. The resin demonstrates anti-inflammatory and analgesic effects through selective CB2 receptor activation without psychoactive properties.
CategoryHerbs (Global Traditional)
GroupAmazonian
Evidence LevelPreliminary
Primary Keywordcopaiba benefits
Copaiba (Copaifera officinalis) — botanical close-up
Health Benefits
Origin & History
Natural habitat
Copaiba is an oleoresin obtained from the trunk of trees in the genus Copaifera, primarily Copaifera officinalis, native to the Amazon rainforest. The resin is extracted via tapping or incision into the tree bark, yielding a pale yellow to greenish oil rich in sesquiterpene hydrocarbons.
“The research dossier provides no specific historical context or traditional medicine systems for copaiba. Its use in traditional Amazonian practices remains undocumented in the sources.”Traditional Medicine
Scientific Research
No human clinical trials, RCTs, or meta-analyses for Copaifera officinalis copaiba were found. One in vitro study evaluated its oleoresin on stem cells, but this was not a human trial.
Preparation & Dosage
Traditional preparation
No clinically studied dosage ranges or forms are available. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Copaiba (Copaifera officinalis) is a resinous oleoresin, not a conventional food ingredient, so traditional macronutrient and micronutrient profiling is not applicable. Its composition is dominated by bioactive compounds: Sesquiterpene hydrocarbons constitute 30–90% of the oleoresin, with β-caryophyllene as the predominant compound at approximately 10–67% depending on species and geographic origin. Other sesquiterpenes include α-humulene (α-caryophyllene) at ~5–15%, β-bisabolene at ~2–8%, ar-curcumene at ~1–5%, and α-copaene at ~1–4%. Diterpene acids (resin fraction) account for approximately 10–56% and include copalic acid (~5–20%), hardwickiic acid (~2–10%), polyalthic acid (~1–5%), and kaurenoic acid (~1–5%). The essential oil fraction contains trace amounts of α-pinene and limonene (<1% each). The oleoresin contains no appreciable macronutrients (carbohydrates, proteins, or lipids in nutritional quantities), no dietary fiber, and no significant vitamins or minerals in concentrations relevant to nutrition. Bioavailability of β-caryophyllene is moderate via oral or topical routes; it is a known selective CB2 cannabinoid receptor agonist, which underlies its anti-inflammatory activity. β-Caryophyllene has demonstrated lipophilicity (log P ~5.5), limiting aqueous solubility but facilitating membrane permeation. Resin acids show limited oral bioavailability without formulation enhancement. Concentrations vary significantly by harvest region, season, and extraction method, making standardization challenging.
How It Works
Mechanism of Action
Copaiba's primary bioactive compound β-caryophyllene selectively binds to cannabinoid CB2 receptors, triggering anti-inflammatory cascades without activating CB1 receptors. This mechanism reduces pro-inflammatory cytokine production including TNF-α and IL-1β while promoting endogenous cannabinoid signaling. The sesquiterpene also modulates cyclooxygenase and lipoxygenase pathways involved in prostaglandin synthesis.
Clinical Evidence
Current research on copaiba relies primarily on in vitro and animal studies rather than human clinical trials. Laboratory studies demonstrate non-cytotoxic effects at low concentrations and confirm anti-inflammatory activity of β-caryophyllene. Animal models show analgesic effects comparable to reference pain medications, but human efficacy data remains limited. The absence of controlled human trials makes it difficult to establish definitive therapeutic dosages or clinical outcomes.
Safety & Interactions
Copaiba appears well-tolerated based on traditional use, but comprehensive safety data is lacking. Potential interactions may occur with medications metabolized through cytochrome P450 enzymes, though specific drug interactions haven't been documented. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with known sesquiterpene allergies should exercise caution, and those taking anticoagulant medications should consult healthcare providers before use.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Copaifera officinaliscopaiba balsamcopaiba oleoresinAmazon copaibacopalBrazilian copaibacopaiba resinbalsam of copaibaJesuit's balsam
Frequently Asked Questions
What is β-caryophyllene in copaiba?
β-caryophyllene is copaiba's primary active sesquiterpene compound, comprising up to 70% of the resin. It uniquely binds to CB2 cannabinoid receptors without psychoactive effects, providing anti-inflammatory benefits through endocannabinoid system modulation.
How much copaiba should I take daily?
No standardized human dosage exists for copaiba due to limited clinical trials. Traditional use suggests 5-15 drops of resin oil daily, but optimal therapeutic doses remain unestablished without controlled studies.
Is copaiba safe during pregnancy?
Copaiba safety during pregnancy hasn't been established through clinical research. Pregnant and breastfeeding women should avoid copaiba supplements due to insufficient safety data and potential effects on fetal development.
Can copaiba interact with blood thinners?
While specific interactions aren't documented, copaiba may theoretically affect blood clotting mechanisms. Individuals taking warfarin, aspirin, or other anticoagulants should consult healthcare providers before using copaiba supplements.
Does copaiba show up on drug tests?
Copaiba shouldn't trigger positive drug tests since β-caryophyllene doesn't activate CB1 receptors and contains no THC. However, product purity varies, so third-party testing verification is recommended for sensitive applications.
What is the difference between copaiba oil and copaiba resin?
Copaiba oil is the oleoresin extracted from Copaifera officinalis trees, commonly used in supplements and topical applications, while copaiba resin refers to the harder, more concentrated form that may be used in traditional medicine and varnishes. The oil form typically contains higher concentrations of volatile sesquiterpenes like β-caryophyllene and is more bioavailable for oral supplementation. Copaiba oil is generally preferred for supplement formulations due to better absorption and standardization.
Who should avoid taking copaiba supplements?
Individuals with known allergies to plants in the Fabaceae family or previous adverse reactions to copaiba should avoid supplementation. People scheduled for surgery should consult healthcare providers, as copaiba's potential effects on bleeding and inflammation may interfere with surgical outcomes or anesthesia. Those with severe liver or kidney disease should also exercise caution, as safety data in these populations is limited.
What does current clinical research actually show about copaiba's effectiveness?
While traditional use and in vitro studies suggest anti-inflammatory and analgesic potential, human clinical trials for copaiba remain limited and inconclusive. Most evidence comes from laboratory studies demonstrating β-caryophyllene's properties rather than whole-plant efficacy in humans. Current research quality is insufficient to make definitive claims about its therapeutic benefits, requiring more rigorous clinical trials before strong conclusions can be drawn.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w copaiba curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
